Morphic Holding, Inc. Uncategorized Contracts & Agreements

11 Contracts & Agreements
Recent Contracts
Category
Company
Industry
Jur. Jurisdiction
Filed
2024 Equity Inducement Plan
Morphic Holding, Inc.
Biotechnology
DE
2024
Amendment No
Morphic Holding, Inc.
Biotechnology
2021
Offer Letter, dated February 20, 2020, by and between the Registrant and Peter Linde
Morphic Holding, Inc.
Biotechnology
2021
Description of Registrants Securities Registered under Section 12 of the Securities Exchange Act of 1934, as amended
Morphic Holding, Inc.
Biotechnology
2021
Offer Letter, dated February 3, 2020, by and between Marc Schegerin, and Morphic Holding, Inc
Morphic Holding, Inc.
Biotechnology
2020
Offer Letter, dated June 10, 2019, by and between the Registrant and William DeVaul
Morphic Holding, Inc.
Biotechnology
2020
Description of Registrants Securities Registered under Section 12 of the Securities Exchange Act of 1934, as amended
Morphic Holding, Inc.
Biotechnology
2020
Offer Letter, dated June 10, 2019, by and between Morphic Therapeutic, Inc. and Alexey A. Lugovskoy, Ph.D., to become effective on the date immediately prior to the date the...
Morphic Holding, Inc.
Biotechnology
2019
Offer Letter, dated June 10, 2019, by and between Morphic Therapeutic, Inc. and Bruce N. Rogers, Ph.D., to become effective on the date immediately prior to the date the...
Morphic Holding, Inc.
Biotechnology
2019
Offer Letter, dated June 10, 2019, by and between Morphic Therapeutic, Inc. and Praveen P. Tipirneni, MD., to become effective on the date immediately prior to the date the...
Morphic Holding, Inc.
Biotechnology
2019
Form of Indemnity Agreement
Morphic Holding, Inc.
Biotechnology
DE
2019